No consistent differences were noted between the maximum total C.E.s between normal and CML CD34+ cells or G0 or G1/S/G2/M subsets, although there was more variability in the quality of the CML samples. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.